Surgical Science Sweden AB (SUS) - Total Liabilities
Based on the latest financial reports, Surgical Science Sweden AB (SUS) has total liabilities worth Skr418.31 Million SEK (≈ $45.02 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore SUS year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Surgical Science Sweden AB - Total Liabilities Trend (2014–2025)
This chart illustrates how Surgical Science Sweden AB's total liabilities have evolved over time, based on quarterly financial data. See Surgical Science Sweden AB free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Surgical Science Sweden AB Competitors by Total Liabilities
The table below lists competitors of Surgical Science Sweden AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Insecticides (India) Limited
NSE:INSECTICID
|
India | Rs7.94 Billion |
|
ASIX Electronics
TWO:3169
|
Taiwan | NT$198.86 Million |
|
Hua Na Hydropower JSC
VN:HNA
|
Vietnam | ₫476.19 Billion |
|
OBOOK Holdings Inc. Class A Common Shares
NASDAQ:OWLS
|
USA | $30.60 Million |
|
Pioneer Municipal High Income Trust
NYSE:MHI
|
USA | $59.28 Million |
|
Amcil Ltd
AU:AMH
|
Australia | AU$32.62 Million |
|
Trivium Real Estate Socimi SA
MC:YTRI
|
Spain | €269.98 Million |
|
Churchill Capital Corp X Class A Ordinary Shares
NYSE:CCCX
|
USA | $27.36 Million |
Liability Composition Analysis (2014–2025)
This chart breaks down Surgical Science Sweden AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Surgical Science Sweden AB worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.09 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Surgical Science Sweden AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Surgical Science Sweden AB (2014–2025)
The table below shows the annual total liabilities of Surgical Science Sweden AB from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr418.31 Million ≈ $45.02 Million |
-35.75% |
| 2024-12-31 | Skr651.03 Million ≈ $70.06 Million |
+82.13% |
| 2023-12-31 | Skr357.46 Million ≈ $38.47 Million |
-13.47% |
| 2022-12-31 | Skr413.11 Million ≈ $44.46 Million |
+5.10% |
| 2021-12-31 | Skr393.06 Million ≈ $42.30 Million |
+769.14% |
| 2020-12-31 | Skr45.22 Million ≈ $4.87 Million |
-17.08% |
| 2019-12-31 | Skr54.54 Million ≈ $5.87 Million |
+168.97% |
| 2018-12-31 | Skr20.28 Million ≈ $2.18 Million |
+51.32% |
| 2017-12-31 | Skr13.40 Million ≈ $1.44 Million |
-67.56% |
| 2016-12-31 | Skr41.30 Million ≈ $4.44 Million |
+17.66% |
| 2015-12-31 | Skr35.10 Million ≈ $3.78 Million |
+200.86% |
| 2014-12-31 | Skr11.67 Million ≈ $1.26 Million |
-- |
About Surgical Science Sweden AB
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquis… Read more